Europe — EMA
Mitoxantron Ebewe (Mitoxantrone)
GNH USA supplies Mitoxantron Ebewe (Mitoxantrone), an anthracenedione for acute leukemias, prostate cancer and progressive multiple sclerosis.
Request sourcing
What is Mitoxantrone?
Mitoxantrone, the active ingredient in Mitoxantron Ebewe, is a anthracenedione presented as a injectable solution for intravenous use. It treats acute myeloid leukemia, acute lymphoblastic leukemia, metastatic hormone‑refractory prostate cancer, and progressive multiple sclerosis in appropriate patients.
GNH USA supplies Mitoxantron Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide.
What is Mitoxantrone used for?
Mitoxantrone is used in hematologic malignancies and certain solid tumours, acting on rapidly dividing cancer cells.
Acute Myeloid Leukemia: improves remission rates in adult patients Acute Lymphoblastic Leukemia: employed for refractory or relapsed disease Metastatic Hormone‑Refractory Prostate Cancer: provides disease control in advanced cases Progressive Multiple Sclerosis: reduces relapse frequency in patients with active disease
What are the side effects of Mitoxantrone?
Adverse reactions may vary in frequency and severity.
Common Side Effects: - Nausea and vomiting - Fatigue - Decreased blood cell counts (neutropenia, anemia) - Alopecia
Serious or Rare Side Effects: - Cardiotoxicity (reduced cardiac function) - Secondary acute leukemia - Severe infection due to immunosuppression - Hepatic toxicity (elevated enzymes, hepatitis)
What precautions apply to Mitoxantrone?
Mitoxantrone requires careful monitoring and specific safety measures.
Monitor blood counts: perform regular complete blood count assessments Assess cardiac function: obtain baseline and periodic ejection‑fraction measurements Evaluate liver function: check hepatic enzymes before and during therapy Avoid use in pregnancy: contraindicated; ensure effective contraception Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake
What does Mitoxantrone interact with?
Mitoxantrone can interact with several medicines, altering efficacy or toxicity.
Major Interactions (Avoid): - Anthracycline chemotherapy agents (additive cardiotoxicity) - Live attenuated vaccines (risk of infection due to immunosuppression) - Strong CYP2D6 inhibitors (increase plasma concentrations)
Moderate Interactions (Monitor Closely): - Azole antifungals (may raise drug levels) - Granulocyte colony‑stimulating factor (can mask neutropenia) - NSAIDs (increase bleeding risk)
